1. Home /
  2. Biotechnology

Biotechnology

Danaher's Earnings Drop on GE Biopharma Acquisition Costs

Danaher's Earnings Drop on GE Biopharma Acquisition Costs

Danaher reports first-quarter earnings that beat analysts' estimates though revises forward guidance on costs related to acquisition of GE's biopharma business.

10 Speculative Stock Plays in the Biotech Sector

10 Speculative Stock Plays in the Biotech Sector

For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.

These 2 Biotech Stocks Are No Longer 'Off the Radar'

These 2 Biotech Stocks Are No Longer 'Off the Radar'

Few parts of the market have more volatility than the small caps in this sector.

Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts

Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts

Healthcare giant Johnson & Johnson reports first-quarter earnings lower than a year earlier but still above analysts' forecasts.

Catalent to Buy Paragon Bioservices for $1.2 Billion

Catalent to Buy Paragon Bioservices for $1.2 Billion

Drugmaker Catalent reaches an agreement to buy closely held Paragon Bioservices, the latest deal in the burgeoning gene-therapy treatment space.

Stalking an Entry in Regeneron Pharmaceuticals

Stalking an Entry in Regeneron Pharmaceuticals

A low-risk countertrend options trade may be worth a look in this name.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Gilead Sciences is partnering with Novo Nordisk to help combat liver disease.

Wave Life Sciences Plunges on Clinical Trial Data Delay

Wave Life Sciences Plunges on Clinical Trial Data Delay

Wave Life Sciences now says its Huntington's disease treatment data won't be available until the end of the year.

Netflix vs. Disney: Whose Streaming Service Should You Bet On?

Netflix vs. Disney: Whose Streaming Service Should You Bet On?

The battle for subscribers and content among streaming video providers is only going to get more intense in 2019. Here is why Disney is the superior investment over Netflix.